OTC fluoride treatment rinses, gels should carry poison warnings on labels -- FDA's Bowen.
This article was originally published in The Tan Sheet
Executive Summary
OTC FLUORIDE TREATMENT RINSES, GELS SHOULD CARRY POISON WARNINGS ON LABELS, FDA OTC Division Director Debra Bowen, MD, said in a June 14 letter to the Nonprescription Drug Manufacturers Association. Responding to a joint request from NDMA and the Cosmetic, Toiletry and Fragrance Association for an exemption from the warnings for OTC fluoride-containing preventive treatment gels and treatment rinses, Bowen said the division "has determined that the first and second general warnings under Sec. 330.1(g) should be required in the labeling."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning